Reversal of platelet aggregation by prostacyclin
- 1 February 1978
- journal article
- research article
- Published by Elsevier in Pharmacological Research Communications
- Vol. 10 (2) , 185-189
- https://doi.org/10.1016/s0031-6989(78)80076-9
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Experimental atherosclerosis in rabbits: Platelet aggregation, thromboxane A2 generation and anti-aggregatory potency of prostacyclinProstaglandins, 1977
- The generation of prostacyclin by arteries and by the coronary vascular bed is reduced in experimental atherosclerosis in rabbitsProstaglandins, 1977
- Effects of prostacyclin (PGX) on cyclic AMP concentrations in human plateletsProstaglandins, 1977
- Modulation of human platelet adenylate cyclase by prostacyclin (PGX)Prostaglandins, 1977
- Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxidesProstaglandins, 1976
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Platelets, Thrombosis and DrugsDrugs, 1975